Skip to main content
Medical Science Educator logoLink to Medical Science Educator
. 2024 Sep 26;34(6):1269–1273. doi: 10.1007/s40670-024-02165-y

Embracing Technology to Develop a Clinical Pharmacology and Medication Safety Elective in Undergraduate Medical Education

William T Wightkin 1, Elizabeth B Graham 2, Brooke Hooper 3, Uzoma Ikonne 1,4,
PMCID: PMC11699176  PMID: 39758487

Abstract

A clinical pharmacology and medication safety elective was developed for fourth-year medical students to enhance students’ foundational pharmacology knowledge and the importance of preventing medication errors. Using video conferencing technology represents a modern approach to facilitate vertical integration of pharmacology curricula and increase multi-institutional and interprofessional collaboration to improve student learning.

Keywords: Medical education, Pharmacology, Medication safety, Technology


Medication errors are associated with extensive financial costs and human harm [1]. Meanwhile, many medical schools are modifying their curriculum to increase clinical exposure to students in the pre-clinical phase restricting the instructional time for pharmacology while the number of new drugs to teach students continues to increase [2]. These findings suggest that students could benefit from more exposure to medical pharmacology before entering medication orders. Medical pharmacology is a broad and complex field of study and limiting medical school pharmacology instruction to only the pre-clinical phase may lead to minimal or no exposure to the clinical application of major topics in pharmacology including medication safety. Applying the approach of the spiral curriculum to pharmacology medical student instruction, where pharmacology topics are revisited to deepen understanding with successive exposure to the topic [3], could solidify and enhance the pharmacology principles learned in the pre-clinical phase. Therefore, offering a fourth-year medical school elective covering core topics in patient and medication safety as well as the safe and cost-effective use of common medications is a strategy that can address these educational concerns.

The COVID-19 pandemic made it necessary for many medical schools to shift to virtual platforms to teach didactic sessions and facilitate online group learning. The use of virtual platforms allowed educators from multiple institutions and professional backgrounds to collaborate and develop new curricula. We used Zoom to collaborate, develop, and implement a 4-week, virtual elective for fourth-year medical students (M4) to expose them to the application of clinical pharmacology principles with pharmacists, physicians, and basic science faculty across three institutions in the spring of 2023. The elective was initially offered to 10 students. All course content was posted to a web-based learning management system and Zoom was used for video-conferenced meetings. Students worked asynchronously viewing videos, reading scientific articles, and working on assessments. Topics included the basics of clinical pharmacology, such as clinically applied pharmacokinetics, drug interactions, renal and hepatic dosing, and the use of drugs in geriatric patients. Specific drug groups were then studied including antimicrobials, analgesics, anticoagulants, and drugs for diabetes. The study of core topics in patient and medication safety was also a primary learning objective. Discussions on error science, error investigation, and just culture were included. Additionally, as each drug group was studied, specific medication safety concerns were identified. The elective included remote synchronous sessions with students. Topics from the preceding week were recapped each Monday. Any questions were answered during these meetings. There was an additional meeting scheduled each elective week: local guest pharmacists and physician experts were recruited to facilitate case study discussions on adverse drug reactions and drug interactions, antimicrobial therapy, fluid and electrolyte imbalances, and computerized clinician drug order entry. The elective sessions and learning objectives are reported in Table 1. The elective course was pass/fail based on attendance at synchronous sessions and completion of problem sets and quizzes. The students were given all answers after the completion of these formative assignments.

Table 1.

Elective content and learning objective: clinical pharmacology and medication safety

WEEK ONE Session title Primary learning objective(s)
Asynchronous sessions Review of pharmacokinetics and pharmacodynamics

Discuss the mathematical and conceptual relationship between dose, volume distribution and plasma concentration

From a serum concentration–time curve, determine a drug’s elimination half-life

Describe the relationship between a kinetic process, its half-life and the time it takes to be (nearly) completed

Explain the concept of drug targets and be able to list several examples of them

Define tolerance, tachyphylaxis, desensitization, refractoriness, and downregulation

Drug dosage forms and routes of administration

Describe the main routes of drug administration as well as their advantages and disadvantages

Be able to match a drug’s route of administration to its serum-concentration time curve

Discuss the pharmacologic significance if a drug’s route of administration bypasses its first-pass effect

Analyzing a drug’s full prescribing information Describe and understand the categories included in a drug’s FDA full prescribing information
Strategies to avoid harm from drug interactions and adverse drug reactions List tactics for preventing and identifying drug interactions and adverse drug reactions
Pharmacology for special populations: patients with renal and hepatic failure; pediatric patients; geriatric patients Describe the impact of these special patient populations on drug use and drug dosing
Problem set on pharmacokinetics and pharmacodynamics Allow the students to apply basic pharmacological principles
Problem set on renal and hepatic failure drug dosing Allow the students to apply drug dosing strategies for these special patient populations
Introduction to Patient Safety

Recognize contributors to unsafe care existing in healthcare

List well-identified safety concerns in patient care that can be improved or eliminated to improve patient outcomes

Describe proactive, reactive and predictive safety methods

Introduction to Medication Safety

Describe the impact of medication errors and adverse drug reactions on patient safety

Explain why there is an emphasis on preventing harm from high alert medications

Synchronous sessions Case studies on adverse drug reactions and drug interactions (facilitator: hospital pharmacist) Discuss how to recognize and prevent drug interactions and adverse drug reactions
WEEK TWO Session title Primary learning objective(s)
Asynchronous sessions Review of antibacterial drug classes For the commonly used antibacterial groups (for examples: penicillins and cephalosporins), describe and compare/contrast the various drugs’ mechanisms of action, spectrums of activity, and adverse effects
Review of current guidelines for treating pneumonia, urinary tract infections, and skin infections Know the current clinical guidelines for the treatment of these common infectious diseases
Clinical pharmacology for analgesics (NSAIDs and Opioids)

Know the mechanisms of action and adverse effects of NSAIDs and opioid analgesics

Develop strategies for the safe use of these analgesics

Clinical pharmacology for insulin and other diabetes medications

Know the mechanisms of action and adverse effects of the various drug categories used in the management of diabetes

Describe current treatment approaches for type 1 and type 2 diabetes

Complete problem sets on pain therapy and diabetes treatment; Complete Bug vs. Drug Comparison Chart for Antibacterials

Give the students an opportunity to construct treatment approaches for the management of pain and diabetes

Be able to compare the spectrum of activities for various antibacterials via completion of the assigned chart

Synchronous sessions Recap discussion on Week One topics; Discussion of Patient Safety Just Culture principles

Describe the role of a robust safety culture in assuring optimal patient safety

Define just culture and describe the use of a just culture algorithm in analyzing patient safety adverse events

Case studies on antimicrobial therapy (facilitators: infectious disease pharmacist and physician) Via presentation and analysis of patient cases, describe the management of common infectious diseases
WEEK THREE Session title Primary learning objective(s)
Asynchronous sessions Antihypertensives

Know the mechanisms of action and adverse effects of the various drug categories used in the management of hypertension

Describe current guidelines regarding the treatment of hypertension

IV fluid and electrolytes

Be able to construct a rational fluid and electrolyte prescription

Describe management of common electrolyte imbalances

Antithrombotic therapy

Know the mechanisms of action and adverse effects of the various drug categories that affect blood coagulation

Describe antithrombotic treatment approaches for acute coronary syndromes, stroke, DVT and pulmonary embolism

List antithrombotics with their recommended reversal agents

Complete problem sets on hypertension management, IV fluid and electrolytes and antithrombotics Give the students an opportunity to construct treatment approaches for the management of hypertension, fluid and electrolyte imbalances and blood clotting disorders
Synchronous sessions Discussion on Week Two topics; discussion on proactive safety techniques; discussion on safety grades for hospitals from Leapfrog Survey

Explain the importance of using proactive methods to prevent harm from healthcare hazards

Describe what patient safety issues can be learned from the hospital Leapfrog Survey

Case-based learning: IV Fluids and Electrolyte (Facilitators: emergency department pharmacist and internal medicine physician) Via presentation and analysis of patient cases, describe the management of common fluid and electrolyte abnormalities
WEEK FOUR Session title Primary learning objective(s)
Asynchronous sessions Application of the just culture algorithm for a fatal medication error After reviewing information about a fatal medication error, analyze the case using the just culture algorithm
Synchronous sessions Controlling the risks of high-alert medications List high alert medications and outline recommended strategies to avoid harm with their use
Medication reconciliation case studies Describe the safety issues with medication reconciliation and list strategies to avoid patient harm from this process
Case-based learning: medication safety when using the electronic medical record (facilitators: hospital pharmacists from 2 local medical centers) Via presentation and analysis of patient cases, describe common errors that accompany medication management using the electronic medical record

Five of the 10 students (50%) responded to the post-elective survey. All survey respondents agreed or strongly agreed that the elective: (1) reinforced their previous knowledge of medical pharmacology, (2) increased their level of confidence in prescribing common medications through the use of case studies, (3) convinced them of the importance of reporting medication errors, and (4) increased their understanding of the pharmacist’s role in patient care. All respondents would recommend this elective to other M4 students. In the open response section of the survey, a student referred to the elective as a “perfect review for students heading into residency.”

Overall, the findings from this study suggest that this 4-week virtual elective was effective in helping support vertical integration of clinical pharmacology content in the curriculum. Further, the results of this study suggest the ability of technology to enhance collaboration across institutions and fields to develop learning opportunities for students.

Data Availability

The datasets generated during or analyzed during the current study are available from the corresponding author on reasonable request.

Declarations

This project was deemed exempt by the Eastern Virginia Medical School Institutional Review Board (IRB # 22–11-XX-0220).

Conflict of Interest

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Donaldson LJ, Kelley ET, Dhingra-Kumar N, Kieny M-P, Sheikh A. Medication without harm: WHO’s third global patient safety challenge. The Lancet. 2017;389(10080):1680–1. [DOI] [PubMed] [Google Scholar]
  • 2.Fasinu PS, Wilborn TW. Pharmacology education in the medical curriculum: challenges and opportunities for improvement. Pharmacol Res Perspect. 2024;12(1):e1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Harden RM. What is a spiral curriculum? Med Teach. 1999;21(2):141–3. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated during or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Medical Science Educator are provided here courtesy of Springer

RESOURCES